Antonio Casini

Antonio studied Biology at the Scuola Normale Superiore in Pisa and obtained his PhD in Biomolecular Sciences at the University of Trento. His research focuses on the development of CRISPR tools for their application in gene therapy. He is author of publications on CRISPR-based genome editing in high impact journals, among which Nature Biotechnology and Nature Communications. He is also inventor of various patents related to genome editing technologies. Antonio is among the founders of Alia Therapeutics, which was launched to exploit CRISPR technologies he helped to co-develop and bring them to the clinic.